Establishment Labs Holdings Inc (ESTA) Actualités

Form 8-K - Current report

Establishment Labs Announces Participation in Upcoming Investment Conferences

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Establishment Labs Announces $50 Million Registered Direct Offering

Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and...

Form 8-K - Current report

Establishment Labs Reports Third Quarter 2024 Financial Results

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness...

Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness...

Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness...

Establishment Labs Publishes 2024 Post Market Surveillance Report

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness...

Form 8-K - Current report